186 related articles for article (PubMed ID: 17337733)
21. Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms.
Ehteshami M; Beilhartz GL; Scarth BJ; Tchesnokov EP; McCormick S; Wynhoven B; Harrigan PR; Götte M
J Biol Chem; 2008 Aug; 283(32):22222-32. PubMed ID: 18547911
[TBL] [Abstract][Full Text] [Related]
22. Steps of the acceptor invasion mechanism for HIV-1 minus strand strong stop transfer.
Chen Y; Balakrishnan M; Roques BP; Bambara RA
J Biol Chem; 2003 Oct; 278(40):38368-75. PubMed ID: 12878597
[TBL] [Abstract][Full Text] [Related]
23. A role of template cleavage in reduced excision of chain-terminating nucleotides by human immunodeficiency virus type 1 reverse transcriptase containing the M184V mutation.
Acosta-Hoyos AJ; Matsuura SE; Meyer PR; Scott WA
J Virol; 2012 May; 86(9):5122-33. PubMed ID: 22379084
[TBL] [Abstract][Full Text] [Related]
24. Ribonuclease H activity during initiation of reverse transcription using tRNA(lys)/RNA primer/template of human immunodeficiency virus.
Artzi HB; Shemesh J; Zeelon E; Amit B; Kleiman L; Gorecki M; Panet A
Arch Biochem Biophys; 1996 Jan; 325(2):209-16. PubMed ID: 8561499
[TBL] [Abstract][Full Text] [Related]
25. Substrate requirements for secondary cleavage by HIV-1 reverse transcriptase RNase H.
Wisniewski M; Chen Y; Balakrishnan M; Palaniappan C; Roques BP; Fay PJ; Bambara RA
J Biol Chem; 2002 Aug; 277(32):28400-10. PubMed ID: 12023278
[TBL] [Abstract][Full Text] [Related]
26. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
[TBL] [Abstract][Full Text] [Related]
27. Acceptor RNA cleavage profile supports an invasion mechanism for HIV-1 minus strand transfer.
Chen Y; Balakrishnan M; Roques BP; Bambara RA
J Biol Chem; 2005 Apr; 280(15):14443-52. PubMed ID: 15657044
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of minus strand strong stop transfer in HIV-1 reverse transcription.
Chen Y; Balakrishnan M; Roques BP; Fay PJ; Bambara RA
J Biol Chem; 2003 Mar; 278(10):8006-17. PubMed ID: 12499370
[TBL] [Abstract][Full Text] [Related]
29. Helix structure and ends of RNA/DNA hybrids direct the cleavage specificity of HIV-1 reverse transcriptase RNase H.
Palaniappan C; Fuentes GM; Rodríguez-Rodríguez L; Fay PJ; Bambara RA
J Biol Chem; 1996 Jan; 271(4):2063-70. PubMed ID: 8567660
[TBL] [Abstract][Full Text] [Related]
30. Effect of ribonucleotides embedded in a DNA template on HIV-1 reverse transcription kinetics and fidelity.
Daddacha W; Noble E; Nguyen LA; Kennedy EM; Kim B
J Biol Chem; 2013 May; 288(18):12522-32. PubMed ID: 23479739
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.
Mbisa JL; Nikolenko GN; Pathak VK
J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835
[TBL] [Abstract][Full Text] [Related]
32. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.
Boso G; Örvell C; Somia NV
J Virol; 2015 Jan; 89(2):1286-97. PubMed ID: 25392207
[TBL] [Abstract][Full Text] [Related]
33. Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein.
Bampi C; Bibillo A; Wendeler M; Divita G; Gorelick RJ; Le Grice SF; Darlix JL
J Biol Chem; 2006 Apr; 281(17):11736-43. PubMed ID: 16500895
[TBL] [Abstract][Full Text] [Related]
34. N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiation.
Biondi MJ; Beilhartz GL; McCormick S; Götte M
J Biol Chem; 2010 Aug; 285(35):26966-26975. PubMed ID: 20530477
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Lim D; Orlova M; Goff SP
J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.
Wu J; Amandoron E; Li X; Wainberg MA; Parniak MA
J Biol Chem; 1993 May; 268(14):9980-5. PubMed ID: 7683687
[TBL] [Abstract][Full Text] [Related]
37. Factors that determine the efficiency of HIV-1 strand transfer initiated at a specific site.
Rigby ST; Van Nostrand KP; Rose AE; Gorelick RJ; Mathews DH; Bambara RA
J Mol Biol; 2009 Dec; 394(4):694-707. PubMed ID: 19853618
[TBL] [Abstract][Full Text] [Related]
38. RNase H activity: structure, specificity, and function in reverse transcription.
Schultz SJ; Champoux JJ
Virus Res; 2008 Jun; 134(1-2):86-103. PubMed ID: 18261820
[TBL] [Abstract][Full Text] [Related]
39. Defects in primer-template binding, processive DNA synthesis, and RNase H activity associated with chimeric reverse transcriptases having the murine leukemia virus polymerase domain joined to Escherichia coli RNase H.
Guo J; Wu W; Yuan ZY; Post K; Crouch RJ; Levin JG
Biochemistry; 1995 Apr; 34(15):5018-29. PubMed ID: 7536033
[TBL] [Abstract][Full Text] [Related]
40. Nucleocapsid protein annealing of a primer-template enhances (+)-strand DNA synthesis and fidelity by HIV-1 reverse transcriptase.
Kim J; Roberts A; Yuan H; Xiong Y; Anderson KS
J Mol Biol; 2012 Feb; 415(5):866-80. PubMed ID: 22210155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
